Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study

被引:23
|
作者
Geraci, G. [1 ]
Palumbo, V. D. [1 ]
D'Orazio, B. [1 ]
Maffongelli, A. [1 ]
Fazzotta, S. [1 ]
Lo Monte, A., I [1 ]
机构
[1] Univ Teaching Hosp Paolo Giaccone Palermo, Sect Gen & Thorac Surg, Palermo, Italy
来源
CLINICA TERAPEUTICA | 2019年 / 170卷 / 05期
关键词
Diclofenac; ERCP; pancreatitis; complication; prevention; COMPLICATIONS;
D O I
10.7417/CT.2019.2156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Post-Endoscopic Retrograde Cholangio-Pancreatography pancreatitis (PEP) is a relevant (1-4%) complication of biliopancreatic operative endoscopy. Rectal nonsteroidal anti-inflammatory drugs (specifically, 100 mg of diclofenac) have shown promising prophylactic activity in PEP. The aim of our prospective study is to report whether prophylactic oral versus rectal suppository versus intramuscular diclofenac versus placebo are able to reduce the incidence and the severity of ERCP-induced pancreatitis. Materials and Methods. in this randomized, double-blinded, prospective study, 100 patients (49 male, 51 female), similar with regard to indication for ERCP, were enrolled between January 2016 and November 2017 to undergo ERCP in the Section of General and Thoracic Surgery of University Hospital of Palermo. They were randomized into five groups, respectively 20 patients with placebo by mouth; 20 patients with 50 mg diclofenac sodium enteric-coated capsules by mouth; 20 with 100 mg rectal suppository diclofenac, 20 with 75 mg/3 ml intramuscular diclofenac sodium, 20 with 75 mg/3 ml intramuscular diclofenac sodium and 20 with 75 mg/3 ml intravenous diclofenac. All drugs were administered 30 to 90 minutes before ERCP. All clinical data were collected one day before and 2, 12 and 24 hour after ERCP. Results. data were prospectively collected and to demonstrate the preventive effect of rectal diclofenac on PEP, a two-by-two table and chi-square test with Yates correction were used: the incidence of PEP was significantly lower (p < 0.001) in the rectal diclofenac group respect to other groups and, in the same way. the incidence of post-ERCP pain was significantly lower in the rectal diclofenac group than in the other groups (p = 0.001) and patients discharge was consequently earlier (p < 0.01). Conclusions. 100 mg dose rectal diclofenac administered 30-60 minutes before ERCP can effectively prevent PEP.
引用
收藏
页码:E332 / E336
页数:5
相关论文
共 50 条
  • [41] Is rectal indomethacin ineffective in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in the general population? Reply
    Feng, Yunlu
    Zhu, Xiang
    Yang, Aiming
    DIGESTIVE ENDOSCOPY, 2017, 29 (03) : 384 - 385
  • [42] Role of Rectal Diclofenac Suppository for Prevention and Its Impact on Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients
    Patil, Sandeep
    Pandey, Vikas
    Pandav, Nilesh
    Ingle, Meghraj
    Phadke, Aniruddha
    Sawant, Prabha
    GASTROENTEROLOGY RESEARCH, 2016, 9 (2-3) : 47 - 52
  • [43] Intramuscular Diclofenac for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Park, Se Woo
    Chung, Moon Jae
    Oh, Tak Geun
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    GASTROENTEROLOGY, 2014, 146 (05) : S298 - S298
  • [44] Clinical outcomes and rates of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in emergency versus elective ERCP cases: A prospective observational study
    Ahmadzai, H.
    Muzhi, Z.
    Thomson, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 6 - 7
  • [45] Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study
    Fujishiro, Hirofumi
    Adachi, Kyoichi
    Imaoka, Tomonori
    Hashimoto, Tomoyuki
    Kohge, Naruaki
    Moriyama, Nobuyuki
    Suetsugu, Hiroshi
    Kawashima, Kousaku
    Komazawa, Yoshinori
    Ishimura, Norihisa
    Ishihara, Shunji
    Amano, Yuji
    Kinoshita, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 1065 - 1069
  • [46] Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
    Tse, Frances
    Yuan, Yuhong
    Bukhari, Majidah
    Leontiadis, Grigorios I.
    Moayyedi, Paul
    Barkun, Alan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
  • [47] Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography
    Guglielmi, V.
    Tutino, M.
    Guerra, V.
    Giorgio, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (22) : 5268 - 5274
  • [48] Nafamostat Mesilate for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis A Prospective, Randomized, Double-Blind, Controlled Trial
    Yoo, Kyo-Sang
    Huh, Kyung Rim
    Kim, Yu Jin
    Kim, Kyoung Oh
    Park, Cheol Hee
    Hahn, Taeho
    Park, Sang Hoon
    Kim, Jong Hyeok
    Park, Choong Kee
    Kwon, Young-Jun
    Lehman, Glen A.
    PANCREAS, 2011, 40 (02) : 181 - 186
  • [49] Prevention Effect of Allopurinol on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-Analysis of Prospective Randomized Controlled Trials
    Cao, Wei-Li
    Yan, Wen-Shan
    Xiang, Xiao-Hui
    Chen, Kai
    Xia, Shi-Hai
    PLOS ONE, 2014, 9 (09):
  • [50] Increased risk of acute pancreatitis in patients with post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: findings from a National Cohort
    Farooq, Umer
    Tarar, Zahid I.
    Kamal, Faisal
    Schlachterman, Alexander
    Kumar, Anand
    Loren, David E.
    Kowalski, Thomas E.
    HPB, 2024, 26 (02) : 313 - 315